MEDNAX Inc
NYSE:MD

Watchlist Manager
MEDNAX Inc Logo
MEDNAX Inc
NYSE:MD
Watchlist
Price: 13.66 USD -0.36% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
MEDNAX Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one MD stock under the Base Case scenario is 26.29 USD. Compared to the current market price of 13.66 USD, MEDNAX Inc is Undervalued by 48%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MD Relative Value
Base Case
26.29 USD
Undervaluation 48%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.6
P/S
P/S
Price to Sales
0.6
vs History
58
vs Industry
84
Median 3Y
0.6
Median 5Y
0.8
Industry
2.3
Forward
0.6
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
43
Median 3Y
11.6
Median 5Y
-0.9
Industry
23.1
Forward
9.8
More Details
8.2
P/OCF
P/OCF
Price to OCF
8.2
vs History
34
vs Industry
45
Median 3Y
7.6
Median 5Y
7.3
Industry
14.2
More Details
11.7
P/FCFE
P/FCFE
Price to FCFE
11.7
vs History
30
vs Industry
24
Median 3Y
12.8
Median 5Y
6.5
Industry
20.1
More Details
1.6
P/B
P/B
Price to Book Value
1.6
vs History
36
vs Industry
70
Median 3Y
1.4
Median 5Y
1.6
Industry
2.2
More Details
0.8
EV/S
EV/S
Enterprise Value to Sales
0.8
vs History
71
vs Industry
76
Median 3Y
0.9
Median 5Y
1.3
Industry
2.4
Forward
0.8
More Details
N/A
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
65
Median 3Y
0
Median 5Y
0
Industry
5
More Details
7.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
7.8
vs History
57
vs Industry
42
Median 3Y
7.9
Median 5Y
9.6
Industry
12.7
Forward
7.2
More Details
9.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
9.5
vs History
52
vs Industry
41
Median 3Y
9.4
Median 5Y
11
Industry
17.1
Forward
8.5
More Details
10.9
EV/OCF
EV/OCF
Enterprise Value to OCF
10.9
vs History
34
vs Industry
35
Median 3Y
11.2
Median 5Y
10.9
Industry
14
More Details
13.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
13.5
vs History
28
vs Industry
27
Median 3Y
13.7
Median 5Y
12.9
Industry
18
More Details
0.9
EV/IC
EV/IC
Enterprise Value to IC
0.9
vs History
39
vs Industry
73
Median 3Y
0.8
Median 5Y
0.9
Industry
1.9
More Details

Multiples Across Competitors

MD Competitors Multiples
MEDNAX Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
MEDNAX Inc
NYSE:MD
1.2B USD 0.6 -4.6 7.8 9.5
US
Cigna Corp
NYSE:CI
78.7B USD 0.3 25.9 8.1 10.4
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.8B EUR 1.3 48.1 11.2 25.8
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49 9.3 18.9
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.4 13.2 20.5
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.5 12.3 16.7
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.8B EUR 0.7 24.1 7 16.3
US
DaVita Inc
NYSE:DVA
12.9B USD 1 15.5 8 11.2
P/E Multiple
Earnings Growth P/E to Growth
US
MEDNAX Inc
NYSE:MD
Average P/E: 27
Negative Multiple: -4.6 		N/A N/A
US
Cigna Corp
NYSE:CI
25.9
96%
0.3
US
C
Cigna Group
XMUN:CGN
25.9
96%
0.3
US
CVS Health Corp
NYSE:CVS
11.3
8%
1.4
DE
Fresenius Medical Care AG
XMUN:FME
48.1
127%
0.4
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.4
263%
0.2
US
Quest Diagnostics Inc
NYSE:DGX
20.5
41%
0.5
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -275.9
4 308%
N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
24.1
127%
0.2
US
DaVita Inc
NYSE:DVA
15.5
61%
0.3

See Also

Summary
MD intrinsic value, competitors valuation, and company profile.
DCF Valuation
MD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MD stock valuation using valuation multiples.
Wall Street Estimates
MD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.